An international collaborative of scientists, including Dr. Ronald Chandler at Michigan State University, studied ARID1A mutations, which are specific gene mutations observed in deep ovarian and deep infiltrating endometriosis. The … Continued
We’re full on into fall, and giving thanks for all that we’ve accomplished together, in a year that’s been more than a little challenging. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS EVENTS WAYS … Continued
A bright spot in 2020 for the ovarian cancer community has been the ongoing developments in research and treatments. Advances continue to be made, as researchers study the effectiveness of … Continued
Want to learn what’s new in ovarian cancer research and care for 2020? Start here. This fall, we hosted our virtual Uniting for Hope Ovarian Cancer National Conference, where experts … Continued
There is an 80% recurrence rate when it comes to ovarian cancer, so the question of ‘what next?’ takes on a huge importance. This is the question that Sarah Gitto, … Continued
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation. Watch the full FDA … Continued
It’s been an incredibly busy end of summer/beginning of fall here at OCRA with a double header of Ovarian Cancer Awareness Month and our Uniting for Hope Ovarian Cancer National Conference. We’ve … Continued
In order to understand the complexities of how gene mutations affect an ovarian cancer diagnosis, OCRA-funded researcher Alexander Nikitin, MD, PhD and colleagues looked to see which ones drive, or … Continued
A new study found that patients who received heated intraperitoneal chemotherapy (HIPEC) after surgery lived almost 16 months longer than patients who were treated by surgery alone. Conducted with data … Continued
Ovarian Cancer Research Alliance (OCRA) is thrilled to announce a groundbreaking partnership with Microsoft’s AI for Health initiative. This unique collaboration will help OCRA accelerate ovarian cancer research by harnessing the power of … Continued
(August 6, 2020) Using medical records for 121 patients with gynecologic cancer and COVID-19, researchers were able to conduct an early look at the implications of a COVID-19 diagnosis on … Continued
(July 27, 2020) Research from the Ovarian Cancer Association Consortium (OCAC) found that “using menopausal hormone therapy prior to diagnosis extends ovarian cancer survival.” This was found through a comprehensive … Continued
Get email updates about research news, action alerts, and ways to join the fight.
